PURPOSE: To evaluate the clinical effect of osteotome sinus floor elevation(OSFE) with or without bone grafting combined with simultaneous implant placement in the treatment of edentulous posterior maxilla.METHODS: A total of 108 implants were placed in 91 patients who underwent OSFE from January 2001 to December 2007.35 were male and 56 were female.The mean age was 44.6 years(between 21 and 60).57 implants(47 patients) were divided into grafting group with Bio-Oss as a grafting material while 51 implants(44 patients) were divided into non-grafting group without grafting material.The residual bone height(RBH) was 5-11mm,and the elevation height was 2-6mm.The mean follow-up time was 56.8 months.Clinical examination and radiographs were conducted.Endo-sinus bone gain and implant length protruding into the sinus were measured on periapical radiographs and cone beam CT(CBCT) scanning among 35 cases(41 implants) during follow-up,analysis of variance and Student's t test were used to analyze the data with SPSS17.0 software package.RESULTS: Seven implants failed in grafting group,and 3 implants failed in non-grafting group,the overall 3-year survival rate was 87.7% and 94.1%,respectively.When sinus floor was raised by 2-4mm,the mean bone gain was(2.7±1.3)mm for the grafting group and(2.4±1.5)mm for non-grafting group.The difference in bone gain between the two groups was not significant.However,the bone gain for grafting group was significantly more(3.5±1.3)mm compared with non-grafting group(1.3±0.4mm) when raised by 4-6mm.CONCLUSIONS: It was predictable and safe when placing implant in the edentulous posterior maxilla after OSFE without grafting material.Grafting material is not necessary to promote osteogenesis beneath the membrane,however,it may gain more bone around implant endo-sinus when utilizing grafting material.